Delivery Room Intervention and Evaluation Network
DRIVE Network
1 other identifier
observational
3,000,000
1 country
1
Brief Summary
The American Academy of Pediatrics (AAP) convened the multi-center Delivery Room Intervention and Evaluation (DRIVE) Network to establish essential infrastructure to collect, coordinate, and analyze core demographic, resuscitative, and outcome data for an inclusive and diverse population of infants who receive delivery room resuscitation at participating centers. The DRIVE Network consists of delivery hospitals across the United States, covering a range of geographic, urban/rural, racial/ethnic diversity across the country. Together, DRIVE seeks to compare practice-level delivery system characteristics, identify best practices, evaluate outcomes from various interventions, and promote professional development through dissemination via the wide reach of the Neonatal Resuscitation Program.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jan 2022
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2022
CompletedFirst Submitted
Initial submission to the registry
January 27, 2025
CompletedFirst Posted
Study publicly available on registry
January 31, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2042
ExpectedStudy Completion
Last participant's last visit for all outcomes
January 1, 2042
January 31, 2025
January 1, 2025
20 years
January 27, 2025
January 27, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Patient disposition
The disposition of the patient after resuscitation including newborn nursery, neonatal ICU including a special care nursery or transitional nursery, palliative care, or transfer to other hospital
Immediately after the resuscitation intervention
Secondary Outcomes (1)
In-hospital mortality
Within 30 days after birth
Study Arms (1)
DRIVE Network Cohort
All infants who receive significant resuscitation intervention (CPAP, PPV, intubation, or CPR) at birth in a DRIVE Network member hospital.
Interventions
Receipt of CPAP, PPV, intubation, or CPR at birth in a hospital delivery room
Eligibility Criteria
All inborn infants who receive significant intervention (CPAP, PPV, intubation, or CPR) at birth in a DRIVE member hospital are included in the DRIVE Database. In addition, summary data is also collected on monthly delivery volume at all sites (stratified by gestational age) to allow for more precise incidence estimates of resuscitative interventions.
You may qualify if:
- Inborn infant in receipt of a significant resuscitation intervention (CPAP, PPV, intubation, or CPR) at birth
You may not qualify if:
- Not live born
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
American Academy of Pediatrics
Itasca, Illinois, 60143, United States
Study Officials
- PRINCIPAL INVESTIGATOR
Elizabeth Foglia, MD MSCE MA FAAP
Perelman School of Medicine at the University of Pennsylvania
- PRINCIPAL INVESTIGATOR
Beena Kamath-Rayne, MD MPH FAAP
American Academy of Pediatrics
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
January 27, 2025
First Posted
January 31, 2025
Study Start
January 1, 2022
Primary Completion (Estimated)
January 1, 2042
Study Completion (Estimated)
January 1, 2042
Last Updated
January 31, 2025
Record last verified: 2025-01
Data Sharing
- IPD Sharing
- Will share
- Time Frame
- Estimated to start in January 2025
For investigators interested in using DRIVE data for observational research, research proposals will be accepted, reviewed, and approved by the DRIVE Steering Committee. Once appropriate regulatory and data use agreements are in place, fully de-identified analytic datasets will be shared for approved protocols. Additionally, at least one DRIVE Steering Committee member will work with the study investigators as a liaison to support the investigators.